Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tandospirone Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114685349A reveals a safer zinc-mediated reduction route for tandospirone intermediates, eliminating palladium risks and ensuring superior purity for API manufacturing.